SUFU and sarcoma: The pleomorphic sarcoma with a concurrent IDH1 R132G mutation and a SUFU splice site mutation may indicate that the Hedgehog (Hh) pathway is operant in these cells independent of SHH ligand expression [39] since SUFU is a negative regulator of Hh signaling [40].